• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Inhibitory Effects of Beta-herpesviruses on Hematopoiesis

Research Project

Project/Area Number 13670299
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Virology
Research InstitutionOkayama University

Principal Investigator

YAMADA Masao  Graduate school of Medicine and Dentistry, Professor, 大学院・医歯学総合研究科, 教授 (40166731)

Co-Investigator(Kenkyū-buntansha) NAMBA Hikaru  Graduate School of Medicine and Dentistry, Research Associate, 大学院・医歯学総合研究科, 助手 (20273972)
ISOMURA Hiroki  Graduate School of Medicine and Dentistry, Research Associate, 大学院・医歯学総合研究科, 助手 (20294415)
YOSHIDA Mariko  Graduate School of Medicine and Dentistry, Assistant Professor, 大学院・医歯学総合研究科, 講師 (20144743)
ARAO Yujirou  Graduate School of Medicine and Dentistry, Research Associate, 医学部, 助教授 (40151146)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2002: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2001: ¥2,400,000 (Direct Cost: ¥2,400,000)
KeywordsHuman herpesvirus 6 (HHV-6) / Human herpesvirus 7 (HHV-7) / Hematopoietic stem cells / CD34 positive cells / Cord blood mononuclear cells
Research Abstract

Human herpesvirus 6 (HHV-6), as well as human cytomegalovirus, is related to various severe complications after hematopoietic stem cell transplantation (SCT) under extensive use of immunosuppressive drugs. We monitored the activity of five herpesviruses including three beta-herpesviruses after allogeneic SCT, and showed that HHV-6 is associated with delayed engraftment of hematopoietic cells after SCT. In vitro models, however, have not proven the relationship between beta-herpesviruses and the clinical manifestations.
We established the in vitro systems to assess the effects of HHV-6 and related beta herpesviruses on hematopoietic colony formation. We comparatively examined HHV-6A, HHV6B, and human herpesvirus 7 (HHV-7). We showed that both type of HHV-6 suppresses all three lineages of hematopoietic colony formation of erythroid (BFU-E), granulocyte /macrophage (CFU-GM), and megakaryocyte (CFU-Meg) in vitro. On the other hand, HHV-7 did not have any suppressive effect on in vitro hema … More topoietic colony formation..
We focused on HHV-6B and further examined the interaction with human CD34+ cells, which are a major source of hematopoietic progenitor cells. CD34+ cells were immunomagnetically isolated from cord blood mononuclear cells using anti-CD34+ antibodies coated onto either Dynabeads or MACS beads. The CD34+ population selected with Dynabeads showed a broad range of fluorescence. The population selected with MACS beads showed a narrow range of fluorescence. After infection with HHV-6, Two transcripts of the immediate early genes were detected with both cell populations. HHV-6 suppressed colony formation of BFU-E, CFU-GM, and CFU-Meg. HHV-6 suppressed cell growth after 3 to 7 days culture in the presence of thrombopoietin (TPO). More differentiated CD34+ cells were more susceptible to the effects of HHV-6. These data indicate that the targets for hematopoietic suppression by HHV-6 are relatively differentiated cells that express a lower amount of the CD34 antigen (dim cells) among a heterogeneous cell population. Less

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Tamada M.: "Human herpesviruses 6 and 7: effects on hematopoiesis and mode of transmission"Jpn J Infect Dis. 54(2). 47-54 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yoshida M.: "Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal Neutralizing antibodies contribute to sequential infection with these viruses in childhood"Clinical and Diagnostic Laboratory Immunology. 9(2). 388-393 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yoshida M.: "Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7 on the basis of neutralizing antibodies"Clinical and Diagnostic Laboratory Immunology. 9(2). 394-402 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ogawa-Goto K.: "An Endoplasmic Reticulum Protein p180, Is Highly Expressed in Human Cytomegalovirus-Permissive Cells and Interacts with the Tegument Protein Encoded by UL48"J Virol. 76(5). 2350-2362 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Isomura H: "The Human Cytomegalovirus Major Immediate-Early Enhancer Determines the Efficiency of Immediate Early Gene Transcription and Viral Replication in Permissive Cells at Low Multiplicity of Infection"J Virol. 77(6). 3702-3711 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Isomura H: "Interaction of human herpesvirus 6 with human CD34 positive cells"J Med Virol. 70. 444-450 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 山田雅夫: "標準微生物学第8版 山西弘一、平松啓一編 分担部分:第7章 III ウイルスの分類"医学書院、東京. 382-387 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamada M: "Human herpesviruses 6 and 7 : effects on hematopoiesis and mode of transmission"Jpn J Infect Dis. 54(2). 47-51 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yoshida M: "Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal Neutralizing antibodies contribute to sequential infection with these viruses in childhood"Clin Diag Lab Immunol. 9 (2). 388-398 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yoshida M: "Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7on the basis of neutralizing antibodies"Clin Diag Lab Immunol. 9 (2). 394-402 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ogawa-Goto K: "An endoplasmic reticulum protein, p180, is highly expressed in human cytomegalovirus-permissive cells and interacts with the tegument protein encoded by UL48"J Virol. 76(5). 2350-2862 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Isomura H: "The human cytomegalovirus mayor immediate-early enhancer determines the efficiency of immediate early gene transcription and viral replication in permissive cells at low multiplicity of infection"J Virol. 77(6). 3702-3711 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Isomura H: "Interaction of human herpesvirus 6 with human CD34 positive cells"J Med Virol. 70. 444-450 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yoshida M.: "Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other, and maternal Neutralizing antibodies contribute to sequential infection with these viruses in childhood"Clinical and Diagnostic Laboratory Immunology. 9(2). 388-393 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Yoshida M.: "Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7 on the basis of neutralizing antibodies"Clinical and Diagnostic Laboratory Immunology. 9(2). 394-402 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ogawa-Goto K.: "An Endoplasmic Reticulum Protein p180, Is Highly Expressed in Human Cytomegalovirus-Permissive Cells and Interacts with the Tegument Protein Encoded by UL48"J Virol. 76(5). 2350-2362 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Isomura H: "The Human Cytomegalovirus Major Immediate-Early Enhancer Determines the Efficiency of Immediate Early Gene Transcription and Viral Replication in Permissive Cells at Low Multiplicity of Infection"J Virol. 77(6). 3702-3711 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Isomura H: "Interaction of human herpesvirus 6 with human CD34 positive cells"J Med Virol. (In press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Yoshida M.: "Neutralizing antibody responses to human herpesviruses 6 and 7 do not cross-react with each other and maternal Neutralizing antibodies contribute to sequential infection with these viruses in childhood"Clinical and Diagnostic Laboratory Immunology. 9(2). 388-393 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yoshida M.: "Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7 on the basis of neutralizing antibodies"Clinical and Diagnostic Laboratory Immunology. 9(2). 394-402 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ogawa-Goto K.: "An Endoplasmic Reticulum Protein, p180, Is Highly Expressed in Human Cytomegalovirus-Permissive Cells and Interacts with the Tegument Protein Encoded by UL48"J Virol. 76(5). 2350-2362 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamada M.: "Human herpesviruses 6 and 7:effects on hematopoiesis and mode of transmission"Jpn J Infect Dis. 54(2). 47-54 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi